Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 64.89% is 83% above its 5-year average of 35.39%, near the high end of its 5-year range (0.35%–68.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.80% above its 12-month average of 64.37%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 64.89%.
DEBT TO ASSETS RATIO
64.89%
DEBT TO ASSETS RATIO AVG TTM
64.37%
DEBT TO ASSETS RATIO AVG 3Y
61.16%
DEBT TO ASSETS RATIO AVG 5Y
35.39%
DEBT TO ASSETS RATIO AVG 10Y
20.43%
DEBT TO ASSETS RATIO AVG 15Y
7.82%
DEBT TO ASSETS RATIO AVG 20Y
8.18%
CURRENT VS TTM AVG
+0.80%
CURRENT VS 3Y AVG
+6.11%
CURRENT VS 5Y AVG
+83.36%
CURRENT VS 10Y AVG
+217.61%
CURRENT VS 15Y AVG
+729.67%
CURRENT VS 20Y AVG
+693.09%
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 389 covered companies
CURRENT VS SECTOR MEDIAN
+49815.86%
vs the sector median at left
Apyx Medical Corporation
Market Cap
$109.49M
Debt to Assets Ratio
64.89%
TTM Avg
64.37%
3Y Avg
61.16%
5Y Avg
35.39%
Market Cap
$108.39M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$111.17M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.23M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$113.77M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$114.24M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.07M
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$116.59M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$117.43M
Debt to Assets Ratio
0.21%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apyx Medical Corporation (APYX) | $109.49M | 64.89% | 64.37% | 61.16% | 35.39% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | 0.03% | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $111.17M | 0.14% | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.23M | 0.07% | N/A | N/A | N/A |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | 0.00% | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $114.24M | 0.01% | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $104.07M | 0.34% | N/A | N/A | N/A |
| Genelux Corporation (GNLX)vs › | $116.59M | 0.09% | N/A | N/A | N/A |
| Foghorn Therapeutics Inc. (FHTX)vs › | $117.43M | 0.21% | N/A | N/A | N/A |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | 0.19% | N/A | N/A | N/A |
Debt/Assets
64.9%
Debt/Equity
3.72
Current Ratio
5.68
Interest Coverage
-1.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 64.89% |
| 2026-03-31 | 62.61% |
| 2025-12-31 | 58.86% |
| 2025-09-30 | 68.36% |
| 2025-06-30 | 67.16% |
| 2025-03-31 | 64.69% |
| 2024-12-31 | 59.78% |
| 2024-09-30 | 63.98% |
| 2024-06-30 | 59.18% |
| 2024-03-31 | 54.62% |
| 2023-12-31 | 48.59% |
| 2023-09-30 | 24.21% |
| 2023-06-30 | 23.09% |
| 2023-03-31 | 16.75% |
| 2022-12-31 | 1.54% |
| 2022-09-30 | 1.47% |
| 2022-06-30 | 1.35% |
| 2022-03-31 | 0.35% |
| 2021-12-31 | 0.44% |
| 2021-09-30 | 0.58% |
| 2021-06-30 | 0.71% |
| 2021-03-31 | 0.78% |
| 2020-12-31 | 0.91% |
| 2020-09-30 | 1.36% |
| 2020-06-30 | 1.42% |
| 2020-03-31 | 1.27% |
| 2019-12-31 | 1.34% |
| 2019-09-30 | 1.30% |
| 2019-06-30 | 0.46% |
| 2019-03-31 | 0.23% |
| 2018-12-31 | 0.15% |
| 2018-09-30 | 0.12% |
| 2018-06-30 | 8.85% |
| 2018-03-31 | 9.21% |
| 2017-12-31 | 9.15% |
| 2017-09-30 | 9.43% |
| 2017-06-30 | 9.07% |
| 2017-03-31 | 9.11% |
| 2016-12-31 | 8.75% |
| 2016-09-30 | 10.75% |
| 2016-06-30 | 10.79% |
| 2016-03-31 | 10.94% |
| 2015-12-31 | 10.53% |
| 2015-09-30 | 9.76% |
| 2015-06-30 | 9.65% |
| 2015-03-31 | 9.69% |
| 2014-12-31 | 13.74% |
| 2014-09-30 | 11.09% |
| 2014-06-30 | 11.18% |
| 2014-03-31 | 11.05% |
| 2013-12-31 | 9.82% |
| 2013-09-30 | 11.98% |
| 2013-06-30 | 12.00% |
| 2013-03-31 | 12.06% |
| 2012-12-31 | 12.13% |
| 2012-09-30 | 13.39% |
| 2012-06-30 | 1.80% |
| 2012-03-31 | 14.06% |
| 2011-12-31 | 14.93% |
| 2011-09-30 | 13.12% |
| 2011-06-30 | 13.20% |
| 2011-03-31 | 13.50% |
| 2010-12-31 | 14.48% |
| 2010-09-30 | 12.84% |
| 2010-06-30 | 13.03% |
| 2010-03-31 | 18.27% |
| 2009-12-31 | 18.46% |
| 2009-09-30 | 19.03% |
| 2009-06-30 | 18.85% |
| 2009-03-31 | 15.97% |
| 2008-12-31 | 15.52% |
| 2008-09-30 | 11.46% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 2.12% |
| 2007-06-30 | 2.16% |
| 2007-03-31 | 2.27% |
| 2006-12-31 | 0.97% |
| 2006-09-30 | 1.38% |
| 2006-06-30 | 1.38% |
| 2006-03-31 | 2.91% |
| 2005-12-31 | 2.96% |
| 2005-09-30 | 3.07% |
| 2005-06-30 | 3.18% |
| 2005-03-31 | 0.28% |
| 2004-12-31 | 3.45% |
| 2004-09-30 | 0.29% |
| 2004-06-30 | 0.30% |
| 2004-03-31 | 0.32% |
| 2003-12-31 | 4.50% |
| 2003-09-30 | 4.75% |
| 2003-06-30 | 3.69% |
| 2003-03-31 | 12.29% |
| 2002-12-31 | 11.40% |
| 2002-09-30 | 6.19% |
